You are here: Industry Insights > oncology

News List

Valeo Pharma Announces $10.0 Million Bought-Deal Public Offering of Units firstwordpharma
June 09, 2021
Valeo Pharma Inc. to announce that it has entered into an agreement with Research Capital Corporation as the lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters pursuant to which the Underwriters has agreed to purchase
COVID vaccine effective for 90% of cancer patients, Israeli study finds firstwordpharma
June 09, 2021
Study findings published in JAMA Oncology showed that nine out of 10 oncology patients develop high antibody levels after receiving COVID-19 vaccines, reported The Times of Israel.
Elekta and Philips deepen strategic partnership in precise and individualized oncology care prnasia
June 07, 2021
Elekta (EKTA-B.ST) and Royal Philips today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions.
BioMedX Extends Collaboration with Merck contractpharma
May 18, 2021
Merck will support up to six more research groups at the BioMed X Institute in Heidelberg within the next six years.
Chinese checkpoint inhibitors may drive down drug prices: GlobalData expresspharma
April 19, 2021
International brands seeking access in China should balance diminishing drug prices with the opportunity to target enormous patient pool.
Doctors keen to adopt novel biomarkers for immuno-oncology regimens: GlobalData expresspharma
March 16, 2021
The most promising or anticipated biomarker among high-prescribing physicians in the seven major markets was identified to be measures of tumour mutational burden.
China continues to lead high value oncology deals in APAC: GlobalData expresspharma
March 15, 2021
High-value deals have dominated the Asia-Pacific (APAC) pharma strategic partnership landscape in 2020. Within the region, China is well ahead of other countries, particularly in the field of oncology, reveals GlobalData.
Enveric Biosciences acquires licence for Diverse Biotech’s novel molecules pharmaceutical-technology
March 12, 2021
Enveric Biosciences has announced the acquisition of an exclusive and perpetual licence for Diverse Biotech’s novel molecules to treat oncology and other debilitating diseases.
New NCCN Guidelines Analyze Evidence for Cancer Type Found Almost Exclusively in Children prnasia
February 18, 2021
The National Comprehensive Cancer Network® (NCCN®) published its first-ever treatment guidelines for children with a solid tumor cancer type in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for ...
mRNA COVID-19 vaccine approvals likely to increase development and approvals in oncology: GlobalData expresspharma
February 01, 2021
The rapid advancement of mRNA vaccine development in recent months – in an attempt to halt the COVID-19 pandemic – is expected to continue to break barriers in the pharma industry, with the oncology market being the most likely to benefit, says GlobalData

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page